HR and breast cancer: Breast cancer includes four widely recognized subtypes: luminal A (hormone receptor positive/human epidermal growth factor receptor 2 negative, HR+/HER2−), luminal B (HR+/HER2+), HR−/HER2+, and triple negative (HR−/HER2−).